Apollo Hospitals is aiming to expand its presence in Indraprastha Medical, subject to court's resumption of operations, as they currently hold a minority stake. The Delhi government, however, holds a significant 26% share in Indraprastha Medical.

Indraprastha Medical's Q4 FY26 net profit increased by 1.7% year-over-year, reaching ₹41.7 Crore. However, the operating margins dropped to 16.6%, causing concern despite a robust 9.3% revenue growth.

Indraprastha Medical Corporation has announced a final dividend of INR 4 per share, providing shareholders with an upcoming payout.

Indraprastha Medical's Q4 EBITDA decreased to ₹604 million, marking a year-on-year drop from ₹615 million. The EBITDA margin also narrowed significantly, falling from 18.4% to 16.6% year-over-year, indicating reduced profitability.

On May 12, 2026, Indraprastha Medical Corporation is set to announce their audited Q4 and FY26 results. The board will also deliberate on proposing a dividend payout for the fiscal year 2025-26.